G211-0103 Screening compound: 2-cyclohexyl-N-(2-ethoxyphenyl)-N-methyl-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

G211-0103 Screening compound: 2-cyclohexyl-N-(2-ethoxyphenyl)-N-methyl-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide
G211-0103 Screening compound: 2-cyclohexyl-N-(2-ethoxyphenyl)-N-methyl-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G211-0103
2-cyclohexyl-N-(2-ethoxyphenyl)-N-methyl-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G211-0103

Molecular Formula

C27H29N3O3 (C27 H29 N3 O3)

Compound Name

2-cyclohexyl-N-(2-ethoxyphenyl)-N-methyl-3-oxo-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

IUPAC name

2-cyclohexyl-N-(2-ethoxyphenyl)-N-methyl-3-oxo-1H2H3H-pyrrolo[34-b]quinoline-9-carboxamide

SMILES

CCOc(cccc1)c1N(C)C(c1c(CN(C2CCCCC2)C2=O)c2nc2ccccc12)=O

InChI

InChI=1S/C27H29N3O3/c1-3-33-23-16-10-9-15-22(23)29(2)26(31)24-19-13-7-8-14-21(19)28-25-20(24)17-30(27(25)32)18-11-5-4-6-12-18/h7-10,13-16,18H,3-6,11-12,17H2,1-2H3

InChI Key

UCQPPUJRVFXECD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14986704

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.813

Distribution Coefficient, logD

4.813

Water Solubility, LogSw

-4.85

Polar Surface Area

47.742

Acid Dissociation Constant (pKa)

17.38

Base Dissociation Constant (pKb)

4.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

G211-0103 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G211-0103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G211-0103?
Check Price and Availability of G211-0103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G211-0103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G211-0103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G211-0103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G211-0103 available by request